Skip to main content

Published locations for EAS lipid guidance: Start high-risk patients on combo drug

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. EAS lipid guidance: Start high-risk patients on combo drug

User login

  • Reset your password
  • /content/eas-lipid-guidance-start-high-risk-patients-combo-drug
  • /familypracticenews/article/242351/cad-atherosclerosis/eas-lipid-guidance-start-high-risk-patients
  • /internalmedicinenews/article/242351/cad-atherosclerosis/eas-lipid-guidance-start-high-risk-patients
  • /clinicalendocrinologynews/article/242351/cad-atherosclerosis/eas-lipid-guidance-start-high-risk
  • /ecardiologynews/article/242351/cad-atherosclerosis/eas-lipid-guidance-start-high-risk-patients-combo
  • /cardiology/article/242351/cad-atherosclerosis/eas-lipid-guidance-start-high-risk-patients-combo-drug
  • /endocrinology/article/242351/cad-atherosclerosis/eas-lipid-guidance-start-high-risk-patients-combo
  • /internalmedicine/article/242351/cad-atherosclerosis/eas-lipid-guidance-start-high-risk-patients
  • /familymedicine/article/242351/cad-atherosclerosis/eas-lipid-guidance-start-high-risk-patients-combo
  • /emergencymedicine/article/242351/cad-atherosclerosis/eas-lipid-guidance-start-high-risk-patients